NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001478

Registered date:25/10/2009

A combination of cinacalcet with maxacalcitol for regression of moderate to advanced secondary hyperparathyroidism in patients on chronic hemodialysis

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedsecondary hyperparathyroidism
Date of first enrollment2008/04/01
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)High doses of cinacalcet and maxacalcitol

Outcome(s)

Primary OutcomeIndication of parathyroidectomy or other intervention therapy by sustained high intact PTH level (>1000 pg/ml)
Secondary Outcome1) Difficulty of management of calcium and phosphate by a combination of cinacalcet and maxacalcitol 2) Low iPTH (<30 pg/ml) 3) Adynamic bone 4) Cardiovascular events

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteria
Exclude criteria1) Uncontrolled ischemic heart disease, heart failure, and arrhythmia 2) Stroke within 6 months 3) Peripheral artery didease of Fontaine 3 and 4 4) Severe liver cirrhosis 5) Malignancy within 3 years 6) Uncontrolled phychosis 7) Attendant for other clinical studies within 3 months 8) Pregnant woman or man who wish for baby 9) Unsuitable patients

Related Information

Contact

public contact
Name Tatsuo Tsukamoto
Address 2-4-20 Ohgimachi, Kita-ku, Osaka Japan
Telephone 06-6312-8831
E-mail
Affiliation Kitano Hospital, The Tazuke Kofukai Medical Institute Division of Nephrology and Dialysis
scientific contact
Name Tatsuo Tsukamoto
Address 2-4-20 Ohgimachi, Kita-ku, Osaka Japan
Telephone 06-6312-8831
E-mail
Affiliation Kitano Hospital, The Tazuke Kofukai Medical Institute Division of Nephrology and Dialysis